Hims & Hers Health SG&A Expenses 2020-2025 | HIMS
Hims & Hers Health annual/quarterly sg&a expenses history and growth rate from 2020 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Hims & Hers Health sg&a expenses for the quarter ending March 31, 2025 were $0.280B, a 69.48% increase year-over-year.
- Hims & Hers Health sg&a expenses for the twelve months ending March 31, 2025 were $0.961B, a 56.65% increase year-over-year.
- Hims & Hers Health annual sg&a expenses for 2024 were $0.847B, a 46.9% increase from 2023.
- Hims & Hers Health annual sg&a expenses for 2023 were $0.576B, a 55.43% increase from 2022.
- Hims & Hers Health annual sg&a expenses for 2022 were $0.371B, a 48.57% increase from 2021.
| Hims & Hers Health Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $847 |
| 2023 | $576 |
| 2022 | $371 |
| 2021 | $250 |
| 2020 | $85 |
| 2019 | $119 |
| 2018 | $0 |
| Hims & Hers Health Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $280 |
| 2024-12-31 | $269 |
| 2024-09-30 | $227 |
| 2024-06-30 | $185 |
| 2024-03-31 | $165 |
| 2023-12-31 | $158 |
| 2023-09-30 | $152 |
| 2023-06-30 | $138 |
| 2023-03-31 | $128 |
| 2022-12-31 | $113 |
| 2022-09-30 | $105 |
| 2022-06-30 | $83 |
| 2022-03-31 | $70 |
| 2021-12-31 | $33 |
| 2021-09-30 | $63 |
| 2021-06-30 | $65 |
| 2021-03-31 | $89 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $35 |
| 2020-06-30 | $27 |
| 2020-03-31 | $27 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.812B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.172B | 60.28 |
| Tempus AI (TEM) | United States | $10.155B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.637B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.007B | 62.61 |
| Hinge Health (HNGE) | United States | $3.004B | 0.00 |
| Privia Health (PRVA) | United States | $2.780B | 190.00 |
| Enovis (ENOV) | United States | $1.805B | 10.06 |
| Schrodinger (SDGR) | United States | $1.749B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.446B | 25.51 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.544B | 162.50 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.378B | 0.00 |
| Outset Medical (OM) | United States | $0.356B | 0.00 |
| TruBridge (TBRG) | United States | $0.353B | 784.00 |
| Health Catalyst (HCAT) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.120B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.072B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |